Comparative Analysis of Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disorder with a complex antiphospholipid antibody-mediated pathogenesis, and high heterogeneity in clinical presentation and disease course. Clinical presentation in antiphospholipid syndrome includes venous and arterial thrombosis, pregnancy complications, and a broad range of microvascular and non-thrombotic manifestations
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults (age ≥18 years)
• Diagnosis of APS based on updated Sydney classification criteria confirmed by: Clinical history of thrombosis and/or pregnancy morbidity, Persistent presence (≥12 weeks) of antiphospholipid antibodies (aCL, anti-β2-glycoprotein I, and/or lupus anticoagulant)
Locations
Other Locations
Egypt
New Valley University
RECRUITING
Al Khārjah
Contact Information
Primary
Asmaa Nady Hussein, MD
asmaanady_1010@med.nvu.edu.eg
01065161752
Time Frame
Start Date: 2025-11-27
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 150
Treatments
1
Primary APS
2
secondary APS
Related Therapeutic Areas
Sponsors
Leads: New Valley University